Pharmacotherapy of focal epilepsy

Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy

(2013) Warrington W. Q. Hsu et al.   CNS DRUGS

Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

(2013) Tracy Glauser et al.   EPILEPSIA

Eslicarbazepine acetate: An update on efficacy and safety in epilepsy

(2013) Alberto Verrotti et al.   EPILEPSY RESEARCH

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

(2013) Kimford J Meador et al.   LANCET NEUROLOGY

Sudden unexpected death in epilepsy (SUDEP): Development of a safety checklist

(2013) Rohit Shankar et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Ezogabine (Retigabine) and Its Role in the Treatment of Partial-Onset Seizures: A Review

(2012) Michele Y. Splinter   CLINICAL THERAPEUTICS

Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305

(2012) Jacqueline A. French et al.   EPILEPSIA

Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: Interim results from phase III, extension study 307

(2012) Gregory L. Krauss et al.   EPILEPSIA

The new ILAE report on terminology and concepts for the organization of epilepsies: Critical review and contribution

(2012) Chrysostomos P. Panayiotopoulos   EPILEPSIA

Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures

(2012) Ivan Rektor   EXPERT OPINION ON PHARMACOTHERAPY

Teratogenic effects of antiepileptic drugs

(2012) Torbjörn Tomson et al.   LANCET NEUROLOGY

Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial

(2012) Michel Baulac et al.   LANCET NEUROLOGY

Randomized phase III study 306: Adjunctive perampanel for refractory partial-onset seizures

(2012) G. L. Krauss et al.   NEUROLOGY

Seizure recurrence after antiepileptic drug withdrawal and the implications for driving: further results from the MRC Antiepileptic Drug Withdrawal Study and a systematic review

(2011) L. J. Bonnett et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial

(2011) Patrick Kwan et al.   LANCET NEUROLOGY

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry

(2011) Torbjörn Tomson et al.   LANCET NEUROLOGY

Incidence of epilepsy: A systematic review and meta-analysis

(2011) A. K. Ngugi et al.   NEUROLOGY

Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy

(2011) J. A. French et al.   NEUROLOGY

Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: A randomized double-blind clinical trial

(2010) Eugene Ramsay et al.   EPILEPSIA

Lacosamide as adjunctive therapy for partial-onset seizures: A randomized controlled trial

(2010) Steve Chung et al.   EPILEPSIA

Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial

(2009) Péter Halász et al.   EPILEPSIA

Neuropathology of focal epilepsies: A critical review

(2009) Ingmar Blümcke   EPILEPSY & BEHAVIOR

The psychosocial impact of epilepsy in adults

(2009) Bruce Hermann et al.   EPILEPSY & BEHAVIOR

Consequences of antiepileptic drug withdrawal: A randomized, double-blind study (Akershus Study)

(2007) Morten Ingvar Lossius et al.   EPILEPSIA